S100A9 and myelodysplastic syndrome: Specifically, Chen et al. showed that MDSCs derived from MDS patients have unusually increased levels of CD33, and this is considered a key factor for their aberrant expansion, since they showed that CD33 can directly interact with S100A9 [78].